Evidence map›Paper›PMID 40639878›Full record

ReviewRMD open2025

Windows for intervention in the prearthritis phase of rheumatoid arthritis? A narrative review of key triggering events and potential preventive strategies.

Alf Kastbom, Sara Turcinov, Vivianne Malmström

Abstract readReview
In one paragraph

Review in RMD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alf KastbomDivision of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden alf.kastbom@liu.se.ORCID 0000-0001-7187-1477
Sara TurcinovDivision of Rheumatology, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.ORCID 0000-0002-7476-1019
Vivianne MalmströmDivision of Rheumatology, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.ORCID 0000-0001-9251-8082

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease that often evolves over several years, which in the presence of risk factors, is termed the at-risk phase. Several of the currently approved treatments for RA have been evaluated for the prevention of RA during the at-risk phase, but without showing effects sufficient to warrant their use prior to diagnosis. There is an ongoing surge in research efforts to understand mechanisms underlying the onset of RA, in particular concerning deviations in the adaptive immune system and the role of mucosal surfaces in the breach of self-tolerance and triggering of arthritis. With this focus, we here aimed to review current knowledge on RA development prior to arthritis onset. Also, since the pre-arthritis phase may contain windows of opportunity to prevent RA onset, we present and conceptualise different strategies to potentially interfere with steps leading to RA. While the body of knowledge is increasing, our understanding of RA development remains incomplete, and available studies highlight that RA appears similarly heterogeneous prior to onset as is seen after diagnosis. Hence, the timing and the selection of subjects will be crucial for the success of future potential interventions.

Indexed as

Antirheumatic AgentsArthritis, RheumatoidDisease ProgressionDisease SusceptibilityHumansRisk FactorsAntirheumatic AgentsArthritis, RheumatoidAutoantibodiesB-LymphocytesT-Lymphocytes

Identifiers

PMID40639878
PMCPMC12258369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.